Latest LSm Stories
ALBANY, N.Y., Oct. 29, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S.
Phase 3 ENDEAR study in infants with SMA enrolling; on track to initiate Phase 3 study in children with SMA later this year CARLSBAD, Calif., Oct.
ALBANY, N.Y., Aug. 26, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S.
Leading Software Maniacs announces the immediate availability of new and updated workshops and eLearning courses that will improve your ability to deliver projects on time and on budget.
--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, March 17, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of clinical studies with
Ribosomes, the cellular machines that build proteins, are themselves made up of dozens of proteins and a few looping strands of RNA.
A study led by St.
Disruptive clumps of mutated protein are often blamed for clogging cells and interfering with brain function in patients with the neurodegenerative diseases known as spinocerebellar ataxias.
Using a new method to catch elusive "jumping genes" in the act, researchers have found two human proteins that are used by one type of DNA to replicate itself and move from place to place.